Goddress
Goddres is an innovative pharmaceutical company established in 2011, committed to research, development, and offering a wide range of high-quality pharmaceutical products. The company's mission is to become a valued pharma partner worldwide by continuously innovating and adhering to global standards. With a focus on healthcare, women’s health, orthopedics, cardiology, diabetology, and gastroenterology, Goddres aims to improve health and well-being through innovative solutions and a culture of excellence, integrity, and teamwork.
Industries
Nr. of Employees
small (1-50)
Products
Pharmaceutical product portfolio across multiple therapeutic areas
A range of pharmaceutical formulations and dosage forms targeted to clinical specialties including women's health, orthopedics, cardiology, diabetology and gastroenterology.
FIBROGESIC
Pregabalin 75 mg + Methylcobalamin 1500mcg tablets indicated for neuropathy.
FIBROGESIC – N
Orthopedic anti-inflammatory tablet formulation.
FIBROGESIC – D
FIBROGESIC-SR
Pregabalin 75 mg + Methylcobalamin 1500mcg tablets indicated for neuropathy.
ALOCK
Orthopedic anti-inflammatory tablet product offering.
Pharmaceutical product portfolio across multiple therapeutic areas
A range of pharmaceutical formulations and dosage forms targeted to clinical specialties including women's health, orthopedics, cardiology, diabetology and gastroenterology.
FIBROGESIC
Pregabalin 75 mg + Methylcobalamin 1500mcg tablets indicated for neuropathy.
FIBROGESIC – N
Orthopedic anti-inflammatory tablet formulation.
FIBROGESIC – D
FIBROGESIC-SR
Pregabalin 75 mg + Methylcobalamin 1500mcg tablets indicated for neuropathy.
ALOCK
Orthopedic anti-inflammatory tablet product offering.
Services
Research services from therapeutic gap identification through formulation development and delivery innovation.
Commercial activities supporting market introduction and distribution of pharmaceutical products to healthcare providers and pharmacies.
Development and delivery of medical information, educational content and stakeholder engagement to support product awareness and appropriate use.
Research services from therapeutic gap identification through formulation development and delivery innovation.
Commercial activities supporting market introduction and distribution of pharmaceutical products to healthcare providers and pharmacies.
Development and delivery of medical information, educational content and stakeholder engagement to support product awareness and appropriate use.
Expertise Areas
- Pharmaceutical research and development
- Women's health (gynecology)
- Orthopedics
- Cardiology
Key Technologies
- Formulation development
- Drug delivery technologies
- Sustained-release / extended-release formulation methods
- Injectable formulation techniques
News & Updates
Scheduled for June 3, 2025, focusing on future strategies.
Awarded on May 28, 2025, recognizing significant contributions.
Recognized on May 28, 2025, for long-term service.
Awarded to PROBLAST SR on February 4, 2025.
Published on February 4, 2025, featuring insights from the CEO.
Recognized as the fastest emerging company by Time Group.
Scheduled for June 3, 2025, focusing on future strategies.
Awarded on May 28, 2025, recognizing significant contributions.
Recognized on May 28, 2025, for long-term service.
Awarded to PROBLAST SR on February 4, 2025.
Published on February 4, 2025, featuring insights from the CEO.
Recognized as the fastest emerging company by Time Group.